Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Short term Debt: 2019

Historic Short term Debt for Neurocrine Biosciences (NBIX) over the last 1 years, with Dec 2019 value amounting to $408.8 million.

  • Neurocrine Biosciences' Short term Debt was N/A to $425.0 million in Q3 2020 from the same period last year, while for Sep 2020 it was $425.0 million, marking a year-over-year change of. This contributed to the annual value of $408.8 million for FY2019, which is N/A change from last year.
  • According to the latest figures from FY2019, Neurocrine Biosciences' Short term Debt is $408.8 million.
  • Over the past 5 years, Neurocrine Biosciences' Short term Debt peaked at $408.8 million during FY2019, and registered a low of $408.8 million during FY2019.
  • Moreover, its 1-year median value for Short term Debt was $408.8 million (2019), whereas its average is $408.8 million.